Recon: BMS buys cell therapy partner 2seventy bio for $286M; Zydus buys majority stake in French device maker Amplitude
ReconJason Scott
Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States